<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2011//EN" "http://www.ncbi.nlm.nih.gov/entrez/query/DTD/pubmed_110101.dtd">
<pubmedarticleset>
 <pubmedarticle>
  <medlinecitation owner="NLM" status="MEDLINE">
   <pmid version="1">
    16818461
   </pmid>
   <datecreated>
    <year>
     2007
    </year>
    <month>
     01
    </month>
    <day>
     23
    </day>
   </datecreated>
   <datecompleted>
    <year>
     2007
    </year>
    <month>
     05
    </month>
    <day>
     08
    </day>
   </datecompleted>
   <daterevised>
    <year>
     2010
    </year>
    <month>
     09
    </month>
    <day>
     15
    </day>
   </daterevised>
   <article pubmodel="Print-Electronic">
    <journal>
     <issn issntype="Print">
      0003-4967
     </issn>
     <journalissue citedmedium="Print">
      <volume>
       66
      </volume>
      <issue>
       2
      </issue>
      <pubdate>
       <year>
        2007
       </year>
       <month>
        Feb
       </month>
      </pubdate>
     </journalissue>
     <title>
      Annals of the rheumatic diseases
     </title>
     <isoabbreviation>
      Ann. Rheum. Dis.
     </isoabbreviation>
    </journal>
    <articletitle>
     Effects of oral glucosamine sulphate on serum glucose and insulin during an oral glucose tolerance test of subjects with osteoarthritis.
    </articletitle>
    <pagination>
     <medlinepgn>
      260-2
     </medlinepgn>
    </pagination>
    <abstract>
     <abstracttext label="BACKGROUND" nlmcategory="BACKGROUND">
      and objective: Glucosamine is suggested to affect glucose transport and insulin resistance. The effects of oral glucosamine on serum glucose and insulin levels at the initiation and throughout the duration of a 3-h oral glucose tolerance test were examined.
     </abstracttext>
     <abstracttext label="METHODS" nlmcategory="METHODS">
      Sera from 16 patients with osteoarthritis, but with no other diagnosed medical condition who had fasted overnight, were obtained every 15-30 min during the 3 h of continued fasting and during the 3 h after ingestion of 75 g of glucose with or without ingestion of 1500 mg of glucosamine sulphate. Glucose was analysed by high-performance liquid chromatography using a Metrohm-Peak 817 Bioscan, and the area under the curve (AUC) for glucose was calculated. Insulin was measured by radioimmunoassay every 30 min for 2 h.
     </abstracttext>
     <abstracttext label="RESULTS" nlmcategory="RESULTS">
      Three participants who were found to have previously undiagnosed abnormalities of glucose tolerance demonstrated significant (p = 0.04) incremental elevations in glucose levels after ingestion of glucosamine sulphate. The other 13 participants also had mean incremental elevations that were not significant (p = 0.20). Glucosamine sulphate ingestion had no effect on insulin levels.
     </abstracttext>
     <abstracttext label="CONCLUSION" nlmcategory="CONCLUSIONS">
      The results suggest that glucosamine ingestion may affect glucose levels and consequent glucose uptake in patients who have untreated diabetes or glucose intolerance.
     </abstracttext>
    </abstract>
    <affiliation>
     Division of Rheumatology, Tufts New England Medical Center, Boston, Massachusetts, USA.
    </affiliation>
    <authorlist completeyn="Y">
     <author validyn="Y">
      <lastname>
       Biggee
      </lastname>
      <forename>
       B A
      </forename>
      <initials>
       BA
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Blinn
      </lastname>
      <forename>
       C M
      </forename>
      <initials>
       CM
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Nuite
      </lastname>
      <forename>
       M
      </forename>
      <initials>
       M
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       Silbert
      </lastname>
      <forename>
       J E
      </forename>
      <initials>
       JE
      </initials>
     </author>
     <author validyn="Y">
      <lastname>
       McAlindon
      </lastname>
      <forename>
       T E
      </forename>
      <initials>
       TE
      </initials>
     </author>
    </authorlist>
    <language>
     eng
    </language>
    <grantlist completeyn="Y">
     <grant>
      <grantid>
       M01-RR00054
      </grantid>
      <acronym>
       RR
      </acronym>
      <agency>
       NCRR NIH HHS
      </agency>
      <country>
       United States
      </country>
     </grant>
     <grant>
      <grantid>
       T-32
      </grantid>
      <agency>
       PHS HHS
      </agency>
      <country>
       United States
      </country>
     </grant>
    </grantlist>
    <publicationtypelist>
     <publicationtype>
      Journal Article
     </publicationtype>
     <publicationtype>
      Research Support, N.I.H., Extramural
     </publicationtype>
     <publicationtype>
      Research Support, Non-U.S. Gov't
     </publicationtype>
     <publicationtype>
      Research Support, U.S. Gov't, Non-P.H.S.
     </publicationtype>
     <publicationtype>
      Research Support, U.S. Gov't, P.H.S.
     </publicationtype>
    </publicationtypelist>
    <articledate datetype="Electronic">
     <year>
      2006
     </year>
     <month>
      07
     </month>
     <day>
      03
     </day>
    </articledate>
   </article>
   <medlinejournalinfo>
    <country>
     England
    </country>
    <medlineta>
     Ann Rheum Dis
    </medlineta>
    <nlmuniqueid>
     0372355
    </nlmuniqueid>
    <issnlinking>
     0003-4967
    </issnlinking>
   </medlinejournalinfo>
   <chemicallist>
    <chemical>
     <registrynumber>
      0
     </registrynumber>
     <nameofsubstance>
      Blood Glucose
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      11061-68-0
     </registrynumber>
     <nameofsubstance>
      Insulin
     </nameofsubstance>
    </chemical>
    <chemical>
     <registrynumber>
      3416-24-8
     </registrynumber>
     <nameofsubstance>
      Glucosamine
     </nameofsubstance>
    </chemical>
   </chemicallist>
   <citationsubset>
    IM
   </citationsubset>
   <commentscorrectionslist>
    <commentscorrections reftype="Cites">
     <refsource>
      Metabolism. 1998 May;47(5):573-7
     </refsource>
     <pmid version="1">
      9591749
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Invest. 1996 Aug 15;98(4):930-6
     </refsource>
     <pmid version="1">
      8770864
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Diabetes. 2000 Jun;49(6):926-35
     </refsource>
     <pmid version="1">
      10866044
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Endocrinol Metab. 2001 May;86(5):2099-103
     </refsource>
     <pmid version="1">
      11344213
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Diabetes Care. 2003 Jun;26(6):1941-2
     </refsource>
     <pmid version="1">
      12766141
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Arch Intern Med. 2003 Jul 14;163(13):1587-90
     </refsource>
     <pmid version="1">
      12860582
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Osteoarthritis Cartilage. 2004 Jun;12(6):506-11
     </refsource>
     <pmid version="1">
      15135147
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Ann Rheum Dis. 2006 Feb;65(2):222-6
     </refsource>
     <pmid version="1">
      16079170
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Biol Chem. 1991 Mar 15;266(8):4706-12
     </refsource>
     <pmid version="1">
      2002019
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Int J Biochem Cell Biol. 1995 Aug;27(8):805-14
     </refsource>
     <pmid version="1">
      7584615
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      J Clin Invest. 1995 Jul;96(1):132-40
     </refsource>
     <pmid version="1">
      7615783
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Diabetes. 1994 Oct;43(10):1173-9
     </refsource>
     <pmid version="1">
      7926284
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Diabetes. 1993 Sep;42(9):1333-46
     </refsource>
     <pmid version="1">
      8349045
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Diabetes. 1996 Aug;45(8):1003-9
     </refsource>
     <pmid version="1">
      8690144
     </pmid>
    </commentscorrections>
    <commentscorrections reftype="Cites">
     <refsource>
      Diabetes. 1999 Aug;48(8):1562-71
     </refsource>
     <pmid version="1">
      10426374
     </pmid>
    </commentscorrections>
   </commentscorrectionslist>
   <meshheadinglist>
    <meshheading>
     <descriptorname majortopicyn="N">
      Adult
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Area Under Curve
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Blood Glucose
     </descriptorname>
     <qualifiername majortopicyn="N">
      analysis
     </qualifiername>
     <qualifiername majortopicyn="N">
      drug effects
     </qualifiername>
     <qualifiername majortopicyn="Y">
      metabolism
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Female
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Glucosamine
     </descriptorname>
     <qualifiername majortopicyn="Y">
      adverse effects
     </qualifiername>
     <qualifiername majortopicyn="N">
      therapeutic use
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Glucose Intolerance
     </descriptorname>
     <qualifiername majortopicyn="N">
      blood
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Glucose Tolerance Test
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Humans
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Insulin
     </descriptorname>
     <qualifiername majortopicyn="Y">
      blood
     </qualifiername>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Male
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Middle Aged
     </descriptorname>
    </meshheading>
    <meshheading>
     <descriptorname majortopicyn="N">
      Osteoarthritis
     </descriptorname>
     <qualifiername majortopicyn="N">
      drug therapy
     </qualifiername>
     <qualifiername majortopicyn="Y">
      metabolism
     </qualifiername>
    </meshheading>
   </meshheadinglist>
   <otherid source="NLM">
    PMC1798503
   </otherid>
  </medlinecitation>
  <pubmeddata>
   <history>
    <pubmedpubdate pubstatus="aheadofprint">
     <year>
      2006
     </year>
     <month>
      7
     </month>
     <day>
      3
     </day>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="pubmed">
     <year>
      2006
     </year>
     <month>
      7
     </month>
     <day>
      5
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="medline">
     <year>
      2007
     </year>
     <month>
      5
     </month>
     <day>
      9
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
    <pubmedpubdate pubstatus="entrez">
     <year>
      2006
     </year>
     <month>
      7
     </month>
     <day>
      5
     </day>
     <hour>
      9
     </hour>
     <minute>
      0
     </minute>
    </pubmedpubdate>
   </history>
   <publicationstatus>
    ppublish
   </publicationstatus>
   <articleidlist>
    <articleid idtype="pii">
     ard.2006.058222
    </articleid>
    <articleid idtype="doi">
     10.1136/ard.2006.058222
    </articleid>
    <articleid idtype="pubmed">
     16818461
    </articleid>
    <articleid idtype="pmc">
     PMC1798503
    </articleid>
   </articleidlist>
  </pubmeddata>
 </pubmedarticle>
</pubmedarticleset>

